Journal Article

Neuraminidase Inhibitors Improve Outcome of Patients with Leukemia and Influenza: An Observational Study

Roy F. Chemaly, Harrys A. Torres, Elizabeth A. Aguilera, Gloria Mattiuzzi, Maria Cabanillas, Hagop Kantarjian, Virginia Gonzalez, Amar Safdar and Issam I. Raad

in Clinical Infectious Diseases

Published on behalf of Infectious Diseases Society of America

Volume 44, issue 7, pages 964-967
Published in print April 2007 | ISSN: 1058-4838
Published online April 2007 | e-ISSN: 1537-6591 | DOI: http://dx.doi.org/10.1086/512374
Neuraminidase Inhibitors Improve Outcome of Patients with Leukemia and Influenza: An Observational Study

More Like This

Show all results sharing these subjects:

  • Infectious Diseases
  • Immunology
  • Public Health and Epidemiology
  • Microbiology

GO

Show Summary Details

Preview

We reviewed the records of 33 patients with leukemia who experienced influenza during the period from October 2000 to March 2004. Three (38%) of the 8 patients who did not receive neuraminidase inhibitor therapy and none of the 25 patients who received it died of influenza pneumonia (P = .001). The use of neuraminidase inhibitor therapy seems to improve the outcome of influenza in patients with leukemia.

Journal Article.  2248 words.  Illustrated.

Subjects: Infectious Diseases ; Immunology ; Public Health and Epidemiology ; Microbiology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.